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ABSTRACT
Introduction: The aim of this study was to determine the prevalence of GBS colonization 
in pregnant women in a public health service. Methods: A study of 496 pregnant women 
at 35-37 gestational weeks was conducted from September 2011 to March 2014 in 21 
municipalities of the 18th Health Region of Paraná State. Vaginal and anorectal samples of 
each woman were plated on sheep blood agar, and in HPTH and Todd-Hewitt enrichment 
broths. Results: Of the 496 pregnant women, 141 (28.4%) were positive for GBS based 
on the combination of the three culture media with vaginal and anorectal samples. The 
prevalence was 23.7% for vaginal samples and 21.9% for anorectal ones. Among the 
variables analyzed in this study, only urinary infection was a significant factor (0.026) 
associated with GBS colonization in women. Conclusions: Based on these results, health 
units should performs universal screening of pregnant women and hospitals should provide 
adequate prophylaxis, when indicated.
KEYWORDS: Streptococcus agalactiae. Colonization. Urinary infections. Pregnant women. 
Public health.
INTRODUCTION 
Maternal colonization by Group B Streptococcus (GBS) is the main risk factor 
for neonatal GBS infection. GBS or Streptococcus agalactiae may be part of the 
human microbiota, mainly colonizing the gastrointestinal and genitourinary tract1. 
About 50 to 75% of newborns exposed to intravaginal GBS become colonized, 
and 1 to 2% of newborns of carrier mothers will develop early-onset invasive 
disease1,2. In the mother, GBS may cause abortion, urinary infection, preterm birth, 
chorioamnionitis or puerperal endometritis3.
A hypothesis of this occurrence might be the hormonal changes occurring during 
the gestational period and the consequent microbiota imbalance, increasing the 
chances of GBS infections which can trigger maternal and child complications1.
In Brazil, some studies have shown different colonization rates by GBS (24.5%, 
16.6%, 27.6%)4-6. In other countries researches have also shown different rates 
(3.3% to 22.76%)7-9. 
Variations in prevalence of GBS colonization in women found in literature can 
be attributed to both, differences in the characteristics of the studied populations 
and the employed bacteriological methodologies2.
 Samples for culture obtained up to four weeks before delivery have greater 
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sensitivity and specificity to identify maternal colonization 
by GBS10. Studies have shown a high rate of transmission to 
newborns during childbirth, as well as increased infection 
and neonatal mortality rate. Given this pathogenic and 
relatively frequent role of vaginal colonization by GBS, 
screening strategies should be adopted between the 35th and 
37th gestational weeks11.
GBS screening in pregnant women and antimicrobial 
prophylaxis (when indicated) may reduce neonatal 
morbidity and mortality; therefore, future studies should 
evaluate the effects and costs of introducing a universal 
infection screening program.
In this sense, this study aimed to verify the prevalence of 
Streptococcus agalactiae colonization in pregnant women 
from public health services.
METHODS
A cross-sectional study was conducted in 21 municipalities 
belonging to the 18th Regional Health Department of Paraná 
State, Brazil. The number of live births in this region in 2010 
was 2,848. The sample was calculated using Epidata software 
by the population proportion method, with the proportion 
of the expected outcome being 50%, a sample error of 4%, 
and a 95% confidence level. Thus, the calculated sample 
was 496 individuals. The following calculation was used 
for stratification of the number of pregnant women in each 
municipality: minimum size of the previously calculated/
total sample of live births from the 18th Regional Health 
Department multipled by the total number of live births from 
each municipality (496/2,848 x number of live births from 
each municipality).
Inclusion criteria of the study were: pregnant women 
with gestational age between 35 and 37 weeks, determined 
from the date of the last menstruation period (DLM) or 
by the fetal ultrasound performed in the first trimester of 
gestation. All participants signed the informed consent 
form. A guardian signed the informed consent form when 
pregnant women were under the age of 18. Pregnant women 
who had been using antimicrobials in the last seven days or 
who used vaginal ointment at the time of collection were 
excluded from the study.
Data collection was performed by the researcher 
between September 2011 and March 2014. When tests 
were scheduled, the researcher went to the municipalities 
to collect the biological samples and to help women to 
fill out a form that contained the following information: 
pregnant woman’s identification, ethnicity, age, educational 
level, marital status, family income, number of pregnancies, 
current gestational data, gestational age, occurrence of 
urinary tract infection during the current gestation, sexually 
transmitted disease prior to or during the current gestation, 
prior miscarriage and number of sexual partners.
 Biological samples were collected from the distal third 
of the vagina by the introduction of sterile swabs through 
the vaginal introitus without speculum. This procedure was 
repeated three times and the samples were labeled as vaginal 
swab 1, 2, and 3. Anorectal samples were collected by the 
introduction of sterile swabs through the anorectal region 
three times and samples were labeled as anorectal swabs 1, 
2, and 3. Vaginal swab 1 and anorectal swab 1 were cultured 
in HPTH culture medium (Hitchens - Pike - Todd - Hewitt) 
supplemented with 100 μL of sterile defibrinated sheep 
blood (Laborclin, São José dos Pinhais, Paraná, Brazil) 
and incubated at 35 °C for 18 to 24 h. After this period of 
incubation, the sample was subcultured into blood agar 
and incubated at 35 °C for 24 to 48 h. Vaginal swab 2 and 
anorectal swab 2 were cultured in Todd-Hewitt culture 
medium (Himedia, Curitiba, Paraná, Brazil) supplemented 
with 8 μg/mL of gentamicin (Inlab, São Paulo, Brazil) and 
15 μg/mL of nalidixic acid (Inlab, São Paulo, Brazil), and 
incubated at 35 °C for 18 to 24 h. The material was then 
subcultured into blood agar (Himedia, Curitiba, Paraná, 
Brazil) and incubated at 35 °C for 24 to 48 h. Vaginal swab 
3 and anorectal swab 3 were immediately cultured in 1/3 
of blood agar medium (Himedia, Curitiba, Paraná, Brazil) 
and incubated at 35 °C for 18 to 24 h.
Streptococcus identification was carried out in the 
Clinical Bacteriology laboratory of the Department 
of Clinical Analysis and Biomedicine (DAB) of the 
Universidade Estadual de Maringá. Colonies that were 
suggestive of GBS (beta- and non-hemolytic) were 
subjected to microscopy (Gram stain), biochemical 
identification (catalase, bile esculin, and hippurate 
hydrolysis) and latex agglutination using a streptococcal 
grouping kit (Oxoid, Hampshire, UK) according to the 
manufacturer’s instructions.
Data were entered into the Microsoft Office Excel 
2007 program and analyzed using the Statistical Analysis 
System (SAS) version 7.3. The chi-squared test was used 
to analyze the relationship between the values with a 5% 
significance level (p=0.05). Results were presented in tables, 
and discussed according to the implemented theoretical 
framework.
The research was approved by the Research Ethics 
Committee of the Universidade Estadual de Maringá, 
Process Nº 236/2011. 
RESULTS
Of the 496 pregnant women at 35-37 gestational weeks 
who participated in the study, 141 (28.4%) were positive for 
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GBS based on the combination of the three culture media 
results from the two clinical specimens. The detected GBS 
colonization rate was 22.2% (IC- 18.52 -25.84) for HPTH 
medium, 21.2% (IC- 17.57- 24.77) for SBA, and 13.1% 
(IC- 10.13 – 16.07) for Todd-Hewitt enrichment broth 
(Figure 1). The prevalence for vaginal samples was 23.7%, 
and 21.9% for anorectal samples.
Regarding socio-demographic data, 72.8% of pregnant 
women were white, 88.1% had one partner, and the age 
group ranged from 14 to 41 years old with an average of 
24.8 years. Evaluation of the educational level followed 
the functional illiteracy criterion adopted by the Brazilian 
Institute of Geography and Statistics (IBGE), showing that 
65.1% of women had studied more than eight years, and 
19.4% had monthly family income of up to two minimum 
wages (Table 1). No statistically significant relationship 
was observed between socio-demographic data and GBS 
colonization (Table 2).
Regarding the gynecological-obstetric characterization, 
the majority was of multiparous (59.7%) with gestational 
age of 35th week (43.1%). The age of first gestation ranged 
from 12 to 39 years; 27.2% were less than 19 years old; 
84.7% had no previous abortion; 3.0% reported a sexually 
transmitted disease in life (among those cited were: HIV, 
Trichomoniasis, HPV, Syphilis, and Chlamydia); 40.1% 
reported urinary tract infection in the current pregnancy; and 
40.0% had only one sexual partner in life. The predominant 
type of delivery was vaginal (59.9%) (Table 3). There was 
only a statistically significant relationship between urinary 
infection during the current gestation and GBS colonization 
in women (0.026) (Table 4).
DISCUSSION
In this study, the frequency of colonization by S. 
agalactiae was 28.4%, and it was higher than that found in 
Figure 1 – Flowchart of culture results, from vaginal and anorectal specimens, in pregnant women at 35-37 gestational weeks 
to detect Streptococcus agalactiae by Hitchens-Pike-Todd-Hewitt (HPTH), Todd-Hewitt enrichment broth and sheep blood agar 
(SBA) culture media
Table 1 - Distribution of pregnant women according to socio-
demographic variables, 18th Regional Department of Health, 
2015
Variables N %
Ethnicity
White 361 72.8
Non-White 135 27.2
Marital Status / Relationship Status
With a partner 437 88.1
Without a partner 59 11.9
Current age
< 20 years 135 27.2
≥ 20 years 361 72.8
Educational level
Up to 8 years of study 173 34.9
More than 8 years of study 323 65.1
Family Income
Up to 1 minimum wage 400  80.6
Up to 2 minimum wages 96 19.4
TOTAL 496 100
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national studies conducted in a Primary Health Units (UBS) 
in São Paulo (17.4%), as well as in private (15.2%) and 
public (22.5%) centers in Rio Grande do Sul10,12,13. Some 
studies performed in other countries have also found lower 
frequencies, ranging from 2.3% to 8.3%14-16.
Prevalence variations of GBS colonization in women 
found in the literature can be attributed to both, differences 
in the characteristics of the studied populations (such 
as age, parity, ethnic group, socioeconomic level and 
geographical location) and to the employed diagnostic 
methods14.
According to CDC, the use of vaginal/rectal swabs 
improves GBS isolation by 40%, compared with vaginal 
specimens alone17. Marconi et al.18 collected material 
from the vaginal introitus, the lateral recess of the vagina 
and the perianal region. Among the patients with positive 
culture, 28.1% were positive at only one collection site, 
24.2% at two sites and 47.5% at the three sites cited. In 
the present study, the vaginal colonization rate was 23.7%, 
and the anorectal rate was 21.9%. When the two sites 
were combined, the rate was of 28.4%. Thus, cultures 
performed with samples from more than one site allow 
the identification of the site from which more GBS can be 
recovered, resulting in more reliable results. 
No significant association was found in this study 
regarding socio-demographic data and GBS colonization 
in women. The same can be observed in the work of other 
researchers7,15.
The Center for Disease Control (CDC)19 recommends 
a gestational age from the 35th week for sample collection 
because there is a greater risk of vertical transmission 
in this period. Colonization of pregnant women at the 
beginning of gestation has no predictive value regarding 
Table 2 - Distribution of pregnant women colonized by GBS according to socio-demographic variables, 18th Regional Department 
of Health, 2015
Variables n % IC 95% p
Ethnicity 0.635
White 100/361 27.70 22.95 – 32.46
Non-White 41/135 30.37 22.24 – 38.50
Marital Status / Relationship Status 0,485
With a partner 127/437 29.06 24.69 – 33.43
Without a partner 14/59 23.73 12.06 – 35.43
Current age 0,520
< 20 years 35/135 25.93 18.16 – 33.69
≥ 20 years 106/361 29.36 24.53 – 34.20
Educational level 0,947
Up to 8 years of study 50/173 28.90 21.86 – 35.95
More than 8 years of study 91/323 28.17 23.11 – 33.23
Family Income 0,069
Up to 1 minimum wage 106/400 26.50 22.05 – 30.95
Up to 2 minimum wages 35/96 36.46 26.31 – 46.61
Table 3 - Distribution of pregnant women according to 
gynecological and obstetric variables, 18th Regional Department 
of Health, 2015
Variables N %
Gestational Age
35 214 43.1
36 138 27.8
37 144 29.1
Number of pregnancies
Primiparous 200 40.3
Multiparous 296 59.7
Sexually Transmitted Disease
Yes 15 3.0
No 481 97.0
Urinary Infection during Pregnancy
Yes 199 40.1
No 297 59.9
Type of delivery*
Vaginal 173 59.9
Cesarean 116 40.1
Number of partners
1 198 40.0
2 113 22.8
3 or more 185 37.2
Use of condom
Yes 23 4.6
No 473 95.4
Abortion
Yes 76 15.3
No 420 84.7
TOTAL 496 100
* The values do not total 496 pregnant women because primipa-
rous and abortions were excluded from this sum, because the risk 
factor for GBS is for women who have had childbirth, regardless 
of the route.
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neonatal infection. This period was determined because it 
is considered that GBS colonization can be transient, and it 
is relevant to know the colonization frequency in the period 
near birth20. In the present study, the majority (43.1%) of 
women was in the 35th week of gestation, and 38.3% of these 
were colonized by GBS; however, the gestational age at the 
time of collection was not associated with the presence of 
GBS (p = 0.387).
Socio-demographic and clinical factors were not 
associated with GBS colonization, but urinary infection at 
some point in the current gestation was a significant risk 
factor. A similar result was found in the study by Mitima 
et al.21 (p <0.05), but it differs from the study by Kruk et 
al.20, in which urinary infection was not significant in GBS 
colonization in women (p = 0.191). It was not possible to 
identify which pathogen caused urinary tract infections in 
pregnant women because this variable was not reported by 
the interviewees. It is known that urinary tract infections 
can cause complications during the gestation period.
CONCLUSION
Although screening is affordable and sample collection 
is simple, GBS culture is still not routinely performed 
during prenatal care in many cities in the country. Public 
policies in the area of maternal and child health have 
been organized in recent decades focusing on expanding 
and improving the quality of obstetric care. However, a 
lack of information regarding the occurrence of infection 
may be responsible for the lack of attention given by 
responsible agencies, both in the prenatal screening and in 
the correct prophylaxis at the time of delivery of colonized 
women.
Since pregnant women colonization was shown to 
be frequent in this study, and GBS can cause neonatal 
sepsis, miscarriage and endometritis, it is recommended 
that health units perform universal screening of pregnant 
women and that hospitals perform prophylaxis, when 
indicated.
Table 4 - Distribution of pregnant women colonized by GBS according to gynecological and obstetric variables, 18th Regional 
Department of Health, 2015
Variables n % IC% p
Gestational Age 0.387
35 54/214 25.23 19.18 - 31.29
36 43/138 31.16 23.07 - 39.25
37 44/144 30.56 22.68 - 38.43
Number of pregnancies 0.783
Primiparous 55/200 27.5 21.06 - 33.94
Multiparous 86/296
Sexually Transmitted Disease 1.00
Yes 4/15 26.67 7.78 - 55.1
No 137/481 28.48 24.34-32.62
Urinary Infection during Pregnancy 0.026
Yes 68/199 34.17 27.33-41.01
No 73/297 24.58 19.51-29.64
Type of delivery* 0.963
Vaginal 52/173 30.06 22.94-37.18
Cesarean 36/116 31.03 22.18-39.88
Number of partners 0.961
1 55/198 27.78 21.28-34.27
2 33/113 29.20 20.38-38.03
3 or more 53/185 28.65 21.86-35.43
Use of condom 0.649
Yes 8/23 34.78 13.14-56.42
No 133/473 28.12 23.96-32.28
Abortion 0.977
Yes 21/76 27.63 16.92-38.34
No 120/420 28.57 24.13-33.01
* The values do not total 496 pregnant women because primiparous and abortions were excluded from this sum, because the risk factor 
for GBS is for women who have had childbirth, regardless of the route.
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